Biohaven Ltd. (NYSE: BHVN) today announced enrollment of the first patient in the pivotal Phase 3 trial of BHV-1300 for ...

ART5 is designed to address the most common root cause of ADPKD by targeting PKD1, potentially restoring PC1 production in approximately 85% of ...

STOCKHOLM, June 30, 2026 (GLOBE NEWSWIRE) -- Salipro Biotech AB today announced the publication of a study in Nature Scientific Reports describing an approach that enables DNA-Encoded Library (DEL) ...

The United States Food and Drug Administration (US FDA) has approved Trutakna (atacicept-vymj), a first-in-class treatment ...

Anupam Ojha, a postdoctoral fellow at the Flatiron Institute, develops advanced statistical frameworks to bridge the gap ...

New study identifies CAR3 as a key osteoblast protein promoting collagen mineralization, bone formation, and skeletal ...

In this episode, I sit down with Sérgio Pinto, the unyielding founder and CEO of Cellva Ingredients, who shares one of the most intense, relentless ...

One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...

A new scientific analysis suggests that drinking multiple cups of coffee a day reduces the risk of liver cancer, liver scarring, and more. This adds to a growing body of research linking coffee to ...

Bacteria that live peacefully in the human gut can aim molecular syringes at intestinal cells and fire proteins directly into ...

Scientists at UCLA have linked long-term exposure to the pesticide chlorpyrifos with a sharply increased risk of Parkinson’s ...